Loading candles…
Shalby Ltd, headquartered in Ahmedabad, India, operates in the healthcare and medical devices industries. The company runs a chain of multi-specialty hospitals across India, offering tertiary and quaternary healthcare services including orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations. In addition to healthcare delivery, Shalby Ltd manufactures medical consumables and implants. It is recognized as a global leader in knee replacement surgery and is regarded as one of the top Indian hospitals in joint replacement surgery, having performed over 175,000 joint replacement surgeries. The company operates one of the largest arthroplasty centers globally. There are no details available regarding its incorporation year, founders, key management, subsidiaries, or stock exchange listings.
This page is a live market overview for SHALBY LIMITED (SHALBY) on the NSE. As a listed security, SHALBY LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SHALBY before placing trades on tick2trade.
As of the latest feed, SHALBY last traded at ₹160.09 on NSE, down ₹2.07 (1.28%) from the previous close of ₹162.16. Today's session range is ₹158.61 – ₹163.97, against a 52-week band of ₹125.82 – ₹274.7. Traded volume today stands at 1.09L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SHALBY in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SHALBY is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SHALBY LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SHALBY. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SHALBY option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | SHALBY : 12-Aug-2026 : The Company has informed the Exchange that a Board meeting to be held on August 05, 2026 has been re-scheduled. Further, the Company … | 12 Aug 2026 |
| Unaudited Results - Q1-FY26 | To consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended Jun 30, 2026 | 5 Aug 2026 |
| Dividend | To consider and approve the audited financial (standalone & consolidated) results for the quarter and year ended March 31, 2026, recommendation of dividend, … | 27 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 11 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025. | 13 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 13 Aug 2025 |
| Audited Results - Q4 & FY25 | To consider and approve the audited financial results for the quarter and year ended March 31, 2025, to recommend dividend, if any and other matters | 29 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.